Directorate Change

RNS Number : 9255B
BMO Private Equity Trust PLC
17 February 2022
 

 

To: Stock Exchange

For immediate release:


17 February 2022

 

BMO Private Equity Trust PLC ("the Company")

LEI: 2138009FW98WZFCGRN66

 

Directorate Change
 

As part of its Board succession plan, the Company announces that Mark Tennant will retire as Chairman at the completion of the Company's 2022 Annual General Meeting ("AGM"). 

 

Mark Tennant joined the Board in February 2009 and was appointed Chairman in May 2010. He has provided the Company with strong leadership and wise counsel throughout his tenure.  The Company has benefited immensely from his extensive knowledge of the financial sector developed from a distinguished career in the City of London.  On behalf of the Company's Shareholders, the Board thanks Mark Tennant for his valued service and leadership.

 

Elizabeth Kennedy, Chair of the Company's Audit Committee, noted that "Mark Tennant's contribution to the success and growth of the Company has been immeasurable.  In addition, he has been a passionate advocate of increasing investor awareness to the benefits of private equity investment".

 

Upon the retirement of Mark Tennant, Richard Gray will be appointed Chairman of the Company.

 

Richard Gray, who joined the Board in March 2017, is a career investment banker with extensive capital markets and corporate finance experience. He has worked previously with Lazard, Charterhouse and UBS and was Vice Chairman of Panmure Gordon. He is a director of Zeus Capital,  a non-executive director of CVS Group plc, an independent director of Alpha Real Capital and Vice Chairman of Invescore Group. 

 

It is anticipated that the Company's AGM will be held on 26 May 2022.

 

For further information please contact:

 

BMO Private Equity Trust PLC


Hamish Mair (Investment Manager)

0131 718 1000

Scott McEllen (Company Secretary)

0131 718 1000

hamish.mair@bmogam.com   /  scott.mcellen@bmogam.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAPAKFSFAEFA
UK 100

Latest directors dealings